A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast ...
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications ...
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not ...
Phase 3 lidERA evaluates daily oral SERD giredestrant in ER+/HER2- early disease, including subgroup analyses by age and menopausal status after a reported 30% risk reduction. Primary ASCENT-04 data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results